Can the implementation of clinical practice guidelines improve clinical competence of physicians and kidney function of patients with type 2 diabetes mellitus?

被引:3
|
作者
Martinez-Martinez, Petra [1 ,2 ]
Cueto-Manzano, Alfonso M. [2 ]
Cortes-Sanabria, Laura [2 ]
Martinez-Ramirez, Hector R. [2 ]
Rojas-Campos, Enrique [2 ]
Hernandez-Herrera, Aurora [3 ]
机构
[1] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Occidente, Inst Mexicano Seguro Social IMSS, Dept Nefrol, Guadalajara, Jalisco, Mexico
[2] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Occidente, Inst Mexicano Seguro Social IMSS, Unidad Invest Med Enfermedades Renales, Guadalajara, Jalisco, Mexico
[3] Inst Mexicano Seguro Social IMSS, Unidad Med Familiar 3, Guadalajara, Jalisco, Mexico
关键词
educative intervention; primary healthcare; diabetes mellitus; chronic kidney disease; clinical practical guidelines; CARE; MANAGEMENT; DOCTORS; DISEASE; CKD;
D O I
10.3389/fmed.2022.977937
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThere are many clinical practice guidelines (CPGs) in Nephrology; however, there is no evidence that their availability has improved the clinical competence of physicians or the outcome of patients with chronic kidney disease (CKD). This study was aimed to evaluate the effect of implementation of CPGs for early CKD on family physicians (FP) clinical competence and subsequently on kidney function preservation of type 2 diabetes mellitus (DM2) patients at a primary healthcare setting. MethodsA prospective educative intervention (40-h) based on CPGs for Prevention, Diagnosis and Treatment of Early CKD was applied to FP; a questionnaire to evaluate clinical competence was applied at the beginning and end of the educative intervention (0 and 2 months), and 12 months afterwards. DM2 patients with CKD were evaluated during 1-year of follow-up with estimated glomerular filtration rate (eGFR) and albuminuria. ResultsAfter educative intervention, there was a significant increase in FP clinical competence compared to baseline; although it was reduced after 1 year, it remained higher compared to baseline. One-hundred thirteen patients with early nephropathy (58 stage 1, 55 stage 2) and 28 with overt nephropathy (23 stage 3, 5 stage 4) were studied. At final evaluation, both groups maintained eGFR [(mean change) early 0.20 +/- 19 pNS; overt 0.51 +/- 13 mL/min pNS], whereas albuminuria/creatinuria (early -67 +/- 155 p < 0.0001; overt -301 +/- 596 mg/g p < 0.0001), systolic blood pressure (early -10 +/- 18 p < 0.05; overt -8 +/- 20 mmHg p < 0.05), and total cholesterol (early -11 +/- 31 p < 0.05; overt -17 +/- 38 mg/dL p < 0.05) decreased. Diastolic blood pressure, waist circumference and LDL-cholesterol were also controlled in early nephropathy patients. ConclusionsCPGs for Prevention, Diagnosis and Treatment of CKD, by means of an educative intervention increases FP clinical competence and improves renal function in DM2 patients with CKD.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Lipid control in the management of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians
    Snow, V
    Aronson, MD
    Hornbake, ER
    Mottur-Pilson, C
    Weiss, KB
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (08) : 644 - 649
  • [42] CLINICAL-PRACTICE GUIDELINES FOR TREATMENT OF DIABETES-MELLITUS
    TAN, MH
    DANEMAN, D
    BEGG, IS
    BENSTEAD, T
    CATELLIER, C
    CHIASSON, JL
    DAWSON, K
    DUFRESNE, J
    EHRLICH, R
    FANTUS, IG
    HAMET, P
    HUNT, JA
    JENNER, M
    LEITER, LA
    MCARTHUR, R
    MCCULLOCH, MA
    MONTOUR, LT
    RODGER, NW
    ROSS, SA
    SIMKINS, S
    WADDELL, C
    WHITING, J
    WORNELL, C
    WRIGHT, LA
    ZINMAN, B
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1992, 147 (05) : 697 - 712
  • [43] Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians
    Qaseem, Amir
    Humphrey, Linda L.
    Sweet, Donna E.
    Starkey, Melissa
    Shekelle, Paul
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (03) : 218 - U92
  • [44] The iSCREEN Electronic Diabetes Dashboard: A Tool to Improve Knowledge and Implementation of Pediatric Clinical Practice Guidelines
    Zahanova, Stacy
    Tsouka, Alexandra
    Palmert, Mark R.
    Mahmud, Farid H.
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (06) : 603 - 612
  • [45] A Study of Barriers and Facilitators of Clinical Practice Guidelines Implementation among Physicians
    Alnaim, Lamya
    Almaz, Saja
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 79 (06) : 923 - 929
  • [46] Physicians' opinions about the implementation of clinical practice guidelines for gastrointestinal oncology
    Duclos, A
    Trillet-Lenoir, V
    Chauvin, F
    Colin, C
    Touzet, S
    PRESSE MEDICALE, 2005, 34 (12): : 851 - 855
  • [47] THE PREVALENCE OF HYPOGONADISM IN MEN WITH TYPE 2 DIABETES MELLITUS IN CLINICAL PRACTICE
    Melnichenko, Galina A.
    Shestakova, Marina V.
    Rozhivanov, Roman V.
    DIABETES MELLITUS, 2019, 22 (02): : 127 - 130
  • [48] INSTITUTIONAL CLINICAL PRACTICE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN MEXICO
    Juarez-Garcia, A.
    Vargas-Valencia, J.
    Martinez-Rivera, G.
    Sotelo-Guzman, M.
    Elias-Lopez, J., I
    Zamora-Barron, M.
    Rangel, S.
    VALUE IN HEALTH, 2011, 14 (07) : A556 - A556
  • [49] Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study
    Franch-Nadal, Josep
    Garcia-Gollarte, Fermin
    Perez del Molino, Alfonso
    Orera-Pena, Maria L.
    Rodriguez de Miguel, Marta
    Melogno-Klinkas, Malena
    de Paz, Hector D.
    Aceituno, Susana
    Rodriguez-Fortunez, Patricia
    CLINICAL DRUG INVESTIGATION, 2019, 39 (01) : 73 - 84
  • [50] Physicians’ and Pharmacists’ Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study
    Josep Franch-Nadal
    Fermín García-Gollarte
    Alfonso Pérez del Molino
    María L. Orera-Peña
    Marta Rodríguez de Miguel
    Malena Melogno-Klinkas
    Héctor D. de Paz
    Susana Aceituno
    Patricia Rodríguez-Fortúnez
    Clinical Drug Investigation, 2019, 39 : 73 - 84